Amanote Research
Register
Sign In
Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits Up to 9 Years of Treatment—Correction
JAMA - Journal of the American Medical Association
- United States
doi 10.1001/jama.290.6.756-a
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
August 13, 2003
Authors
Unknown
Publisher
American Medical Association (AMA)
Related search
Hydroxyurea Treatment Decreases Glomerular Hyperfiltration in Children With Sickle Cell Anemia
American Journal of Hematology
Hematology
Mortality in Sickle Cell Patients on Hydroxyurea Therapy
Blood
Biochemistry
Immunology
Cell Biology
Hematology
The Influence of Hydroxyurea on Oxidative Stress in Sickle Cell Anemia
Revista Brasileira de Hematologia e Hemoterapia
The Effect of Sickle Cell Genetic Markers on Geographic Distribution and Relation to Pain Outcomes in the Multicenter Study of Hydroxyurea in Sickle Cell Anemia
Oncology & Hematology Review (US)
Hydroxyurea Enhances Fetal Hemoglobin Production in Sickle Cell Anemia.
Journal of Clinical Investigation
Medicine
Hydroxyurea Prevents Onset and Progression of Albuminuria in Children With Sickle Cell Anemia
American Journal of Hematology
Hematology
The Effect of Hydroxyurea in Sickle Cell Disease Patients
IOSR Journal of Dental and Medical Sciences
Effect of Hydroxyurea on Priapism in Men With Sickle Cell Disease
West Indian Medical Journal
Medicine
“Maximum Tolerated Dose” Versus “Fixed Low-Dose” Hydroxyurea for Treatment of Adults With Sickle Cell Anemia
American Journal of Hematology
Hematology
